The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Open accessAbstract
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the identified genomic alterations (GAs) in PDAC, oncogenic KRAS mutations are the most common, occurring in close to 90% of patients, followed by TP53, CDKN2A, and SMAD47,8.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [7]
In the citing paper
“Amongst these are four canonical mutations – KRAS (~85%), TP53 (60–70%), CDKN2A (>50%), and SMAD4 (~50%).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Self-citationNeoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,395
Self-citationThe patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Self-citationExome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,302
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,002
Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC
Yang, Y., Wang, X., Yang, J., Duan, J., Wu, Z., Yang, F., Zhang, X., & Xiao, S. (2019) · Cancer Management and Research · doi:10.2147/cmar.s207329 · Cited by 41
Imaoka, H., Sasaki, M., Hashimoto, Y., Watanabe, K., & Ikeda, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081173 · Cited by 42
siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy
Luo, D., Xu, X., Iqbal, M. Z., Zhao, Q. D., Zhao, R., Farheen, J., Zhang, Q., Zhang, P., & Kong, X. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091428 · Cited by 40
Grierson, P. M., Tan, B. R., Pedersen, K. S., Park, H., Suresh, R., Amin, M. A., Trikalinos, N. A., Knoerzer, D. L., Kreider, B. L., Reddy, A., et al. (2022) · The Oncologist · doi:10.1093/oncolo/oyac237 · Cited by 41
Yang, X., Ma, Y., Liu, Y., Jiang, X., Ding, H., Shi, Y., Jia, C., Lu, G., Zhang, D., Wang, H., et al. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110025 · Cited by 40
Quercetin Mediates β-Catenin in Pancreatic Cancer Stem-Like Cells
Cao, C., Sun, L., Mo, W., Sun, L., Luo, J., Yang, Z., & Ran, Y. (2015) · Pancreas · doi:10.1097/mpa.0000000000000400 · Cited by 40
Integrated proteo-genomic approach for early diagnosis and prognosis of cancer
Shukla, H. D., Mahmood, J., & Vujašković, Ž. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.003 · Cited by 42
Bhoopathi, P., Quinn, B. A., Gui, Q., Shen, X., Grossman, S. R., Das, S. K., Sarkar, D., Fisher, P. B., & Emdad, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0819 · Cited by 40
Wong, M. H., Xue, A., Baxter, R. C., Pavlakis, N., & Smith, R. C. (2016) · Neoplasia · doi:10.1016/j.neo.2016.06.001 · Cited by 40
Conner, J., Mariño‐Enríquez, A., Mino-Kenudson, M. A., Garcia, E. P., Pitman, M. B., Sholl, L. M., Srivastava, A., & Doyle, L. A. (2017) · Pancreas · doi:10.1097/mpa.0000000000000805 · Cited by 40
DNA Damage Repair System in Plants: A Worldwide Research Update
Giménez, E., & Manzano-Agugliaro, F. R. (2017) · Genes · doi:10.3390/genes8110299 · Cited by 40
Shouksmith, A. E., Shah, F., Grimard, M., Gawel, J. M., Raouf, Y. S., Geletu, M., Berger‐Becvar, A., de Araujo, E. D., Luchman, H. A., Heaton, W. L., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01957 · Cited by 40
Lin, T., Ren, Q., Zuo, W., Jia, R., Xie, L., Lin, R., Zhao, H., Chen, J., Yan, L., Wang, P., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1160-9 · Cited by 40
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Vivet-Noguer, R., Tarin, M., Roman‐Roman, S., & Alsafadi, S. (2019) · Cancers · doi:10.3390/cancers11071019 · Cited by 43
RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas
Chou, A. S. Y., Brown, I., Kumarasinghe, P. M., Perren, A. A., Riley, D., Kim, Y., Pajic, M., Steinmann, A. M., Rathi, V., Jamieson, N. B., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0373-y · Cited by 40
Self-citationMechanically stressed cancer microenvironment: Role in pancreatic cancer progression
Hadden, M. K., Mittal, A., Samra, J. S., Zreiqat, H., Sahni, S., & Ramaswamy, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188418 · Cited by 40
Self-citationXu, F., Wu, L., Chang, C., He, Q., Zhang, Z., Liu, L., Shi, W.-H., Guo, J., Zhu, Y., Zhao, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms9806 · Cited by 41
Fan, S., Tang, J., Li, N., Zhao, Y., Ai, R., Zhang, K., Wang, M., Du, W., & Wang, W. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0077-8 · Cited by 48
Self-citationKasuga, A., Okamoto, T., Udagawa, S., Mori, C., Mie, T., Furukawa, T., Yamada, Y., Takeda, T., Matsuyama, M., Sasaki, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031205 · Cited by 41
Dudgeon, C., Casabianca, A., Harris, C. R., Ogier, C., Bellina, M., Fiore, S., Bernet, A., Ducarouge, B., Goldschneider, D., Su, X., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113369 · Cited by 37
Zhu, B., Tian, J., Zhong, R., Tian, Y., Chen, W., Qian, J., Zou, L., Xiao, M., Shen, N., Yang, H. B., et al. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22140 · Cited by 39
Al‐Ejeh, F., Pajic, M., Shi, W., Kalimutho, M., Miranda, M. S., Nagrial, A. M., Chou, A. S. Y., Biankin, A. V., Grimmond, S. M., Initiative, F. T. A. P. C. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0048 · Cited by 39
Self-citationVoorneveld, P. W., Stache, V., Jacobs, R. J., Smolders, E., Sitters, A. I., Liesker, A., Korkmaz, K., Lam, S. M., de Miranda, N. F. C. C., Morreau, H., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.486 · Cited by 39
The genomic landscape of chronic lymphocytic leukemia: clinical implications
Quesada, V., Ramsay, A. J., Rodrı́guez, D., Puente, X. S., Campo, E., & López-Otı́n, C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-124 · Cited by 39
Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
Pompella, L., Tirino, G., Pappalardo, A., Caterino, M., Ventriglia, A., Nacca, V., Orditura, M., Ciardiello, F., & Vita, F. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082814 · Cited by 40
Thompson, E. D., Roberts, N. J., Wood, L. D., Eshleman, J. R., Goggins, M., Kern, S. E., Klein, A. P., & Hruban, R. H. (2020) · Modern Pathology · doi:10.1038/s41379-020-0629-6 · Cited by 41
Self-citationExpression and prognostic values of ARID family members in breast cancer
Zhang, J., Hou, S., You, Z., Li, G., Xu, S., Li, X., Zhang, X., Lei, B., & Pang, D. (2021) · Aging · doi:10.18632/aging.202489 · Cited by 39
Saiyin, H., Ardito-Abraham, C., Wu, Y., Wei, Y., Fang, Y., Han, X., Li, J., Zhou, P., Qing, Y., Maitra, A., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4506 · Cited by 39
Self-citationBerry, W., Algar, E. M., Kumar, B., Desmond, C., Swan, M. P., Jenkins, B. J., & Croagh, D. G. (2017) · International Journal of Cancer · doi:10.1002/ijc.30648 · Cited by 40
Grossmann, A. H., Zhao, H., Jenkins, N., Zhu, W., Richards, J. R., Yoo, J. H., Winter, J. M., Rich, B. E., Mleynek, T., Li, D. Y., et al. (2016) · Small GTPases · doi:10.1080/21541248.2016.1259710 · Cited by 39
Self-citationImpact of Alternative Splicing Variants on Liver Cancer Biology
Marín, J., Reviejo, M., Soto, M., Lozano, E., Asensio, M., Ortiz-Rivero, S., Berasain, C., Avila, M., & Herráez, E. (2021) · Cancers · doi:10.3390/cancers14010018 · Cited by 24
Li, O., Li, L., Sheng, Y., Ke, K., Wu, J., Mou, Y., Liu, M., & Jin, W. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216391 · Cited by 38
Self-citationMetabolic Features of Cancer Treatment Resistance
Viale, A., & Draetta, G. F. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_6 · Cited by 36
Stratford, J. K., Yan, F., Hill, R. A., Major, M. B., Graves, L. M., Der, C. J., & Yeh, J. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174863 · Cited by 38
Dutta, P., Perez, M. V. R., Lee, J.-H., Kang, Y., Pratt, M. F., Salzillo, T. C., Weygand, J., Zacharias, N. M., Gammon, S. T., Koay, E. J., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00132 · Cited by 38
Self-citationBehind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
Arner, E. N., Du, W., & Brekken, R. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01049 · Cited by 40
RAF1 rearrangements are common in pancreatic acinar cell carcinomas
Prall, O. W. J., Nastevski, V., Xu, H., McEvoy, C. R. E., Vissers, J. H. A., Byrne, D. J., Takano, E. A., Yerneni, S., Ellis, S. L., Green, T., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0545-9 · Cited by 38
Self-citationGenomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 41
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
Yoshimi, A., & Abdel-Wahab, O. I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0131 · Cited by 39
Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing
Sabir, S. H., Krishnamurthy, S., Gupta, S. K., Mills, G. B., Wei, W., Cortés, A., Shaw, K. R. M., Luthra, R., & Wallace, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189651 · Cited by 38
Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 37
Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside
Sriramulu, S., Thoidingjam, S., Brown, S. L., Siddiqui, F., Movsas, B., & Nyati, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114126 · Cited by 39
Li, Q., Zhang, X.-X., Hu, L.-P., Li, D., Li, D.-X., Wang, X., Jiang, S.-H., Li, H., Yang, M.-W., Jiang, Y.-S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36521-0 · Cited by 39
Ayoub, M., Faris, C., Juranovic, T., Chela, H. K., & Daglilar, E. S. (2024) · Cancers · doi:10.3390/cancers16091625 · Cited by 38
Murphy, S. J., Hart, S. N., Halling, G. C., Johnson, S. H., Smadbeck, J. B., Drucker, T., Lima, J. F., Rohakhtar, F. R., Harris, F. R., Kosari, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2198 · Cited by 37
Self-citationAkamatsu, M., Makino, N., Ikeda, Y., Matsuda, A., Ito, M., Kakizaki, Y., Saito, Y., Ishizawa, T., Kobayashi, T., Furukawa, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158669 · Cited by 37
Biomarkers of genome instability and cancer epigenetics
Reis, A. H. O., Vargas, F. R., & Lemos, B. (2016) · Tumor Biology · doi:10.1007/s13277-016-5278-5 · Cited by 40
Pinho, A. V., Mawson, A., Gill, A. J., Arshi, M., Warmerdam, M., Giry-Laterrière, M., Eling, N., Lie, T., Kuster, E., Camargo, S. M. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11013 · Cited by 37
Self-citationLal, S., Zarei, M., Chand, S. N., Dylgjeri, E., Mambelli-Lisboa, N. C., Pishvaian, M. J., Yeo, C. J., Winter, J. M., & Brody, J. R. (2016) · Scientific Reports · doi:10.1038/srep33323 · Cited by 37
Differential network analysis from cross-platform gene expression data
Zhang, X.-F., Ou-Yang, L., Zhao, X., & Yan, H. (2016) · Scientific Reports · doi:10.1038/srep34112 · Cited by 37
Takai, E., Totoki, Y., Nakamura, H. K., Kato, M., Shibata, T., & Yachida, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42044-8_3 · Cited by 38
Thillai, K., Lam, H., Sarker, D., & Wells, C. M. (2016) · Oncotarget · doi:10.18632/oncotarget.13309 · Cited by 37
Zhang, L., Luo, M., Yang, H., Zhu, S., Cheng, X., & Qing, C. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0494-4 · Cited by 37
Noise-reducing optogenetic negative-feedback gene circuits in human cells
Guinn, M. T., & Balázsi, G. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz556 · Cited by 38
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma
Lee, H.-J., Pham, T., Chang, M. T., Barnes, D., Cai, A. G., Noubade, R., Tótpál, K., Chen, X., Tran, C., Hagenbeek, T. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1704 · Cited by 38
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma
Ahmad-Nielsen, S. A., Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152985 · Cited by 37
Corradi, C., Gentiluomo, M., Gajdán, L., Cavestro, G. M., Kreivėnaitė, E., Franco, G. D., Sperti, C., Giaccherini, M., Petrone, M. C., Tavano, F., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33475 · Cited by 37
Self-citationGiannis, D., Moris, D., & Barbas, A. S. (2021) · Cancers · doi:10.3390/cancers13051071 · Cited by 37
Grant, R. C., Al-Sukhni, W., Borgida, A., Holter, S., Kanji, Z. S., McPherson, T. A., Whelan, E. R., Serra, S., Trinh, Q. M., Peltekova, V. D., et al. (2013) · Human Genomics · doi:10.1186/1479-7364-7-11 · Cited by 37
Self-citationŞahin, İ. H., Iacobuzio–Donahue, C. A., & O'Reilly, E. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1094057 · Cited by 39
Self-citationJahan, R., Macha, M. A., Rachagani, S., Das, S., Smith, L. M., Kaur, S., & Batra, S. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.008 · Cited by 37
Evolution and Controllability of Cancer Networks: A Boolean Perspective
Srihari, S., Raman, V., Leong, H. W., & Ragan, M. A. (2013) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2013.128 · Cited by 38
Neuronal guidance genes in health and diseases
Yuasa‐Kawada, J., Kinoshita-Kawada, M., Tsuboi, Y., & Wu, J. Y. (2022) · Protein & Cell · doi:10.1093/procel/pwac030 · Cited by 37
Self-citationVasseur, R., Skrypek, N., Duchêne, B., Renaud, F., Martínez‐Maqueda, D., Vincent, A., Porchet, N., SEUNINGEN, I. V., & Jonckheere, N. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.10.014 · Cited by 40
Understanding pancreatic cancer genomes
Cowley, M. J., Chang, D. K.-F., Pajic, M., Johns, A. L., Waddell, N., Grimmond, S. M., & Biankin, A. V. (2013) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-013-0610-6 · Cited by 36
Self-citationWeng, Y., Ma, J., Zhang, J., & Wang, J. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1529110 · Cited by 36
RetractedCai, L., Chen, Y., Tong, X., Wu, X., Bao, H., Shao, Y. W., Luo, Z., Wang, X., & Cao, Y. (2021) · International Journal of Cancer · doi:10.1002/ijc.33583 · Cited by 36
Histone methylation in pancreatic cancer and its clinical implications
Liu, X., Guo, C.-H., Xi, Z.-Y., Xu, X.-Q., Zhao, Q.-Y., Li, L., & Wang, Y. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i36.6004 · Cited by 36
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 39
Self-citationLeung, L., Radulovich, N., Zhu, C., Wang, D. Y. Q., To, C., Ibrahimov, E., & Tsao, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084366 · Cited by 40
Self-citationGökmen‐Polar, Y., Neelamraju, Y., Goswami, C. P., Gu, X., Nallamothu, G., Janga, S. C., & Badve, S. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.146 · Cited by 36
Tripaldi, R., Stuppia, L., & Alberti, S. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.02.002 · Cited by 36
Bechard, M. E., Smalling, R., Hayashi, A., Zhong, Y., Word, A. E., Campbell, S. L., Tran, A. V., Weiss, V. L., Iacobuzio-Donahue, C., Wellen, K. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17839-5 · Cited by 33
Self-citationGeorge, B., Kudryashova, O. M., Kravets, A. D., Thalji, S. Z., Malarkannan, S., Kurzrock, R., Chernyavskaya, E. F., Gusakova, M., Kravchenko, D., Tychinin, D. I., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.028 · Cited by 35
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Xie, C., Liao, C., Lin, H.-Y., Wu, Y., Lu, F.-C., Huang, X., Wang, Z., Li, G., Lin, C., Hu, J., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02128-2 · Cited by 37
Liu, Y., Lin, J., Yu, Z., Li, X., Lv, X., Liu, P., Sun, X., Zhang, Z., Gao, X., Sun, K., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.07.008 · Cited by 40
Cooperation between Noncanonical Ras Network Mutations
Stites, E. C., Trampont, P. C., Haney, L. B., Walk, S. F., & Ravichandran, K. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.035 · Cited by 35
Chromatin-regulating proteins as targets for cancer therapy
Oike, T., Ogiwara, H., Amornwichet, N., Nakano, T., & Kohno, T. (2014) · Journal of Radiation Research · doi:10.1093/jrr/rrt227 · Cited by 37
Yong, L.-K., Lai, S., Liang, Z., Poteet, E. C., Chen, F., Buren, G. V., Fisher, W. P., Mo, Q., Chen, C., & Yao, Q. C. (2016) · Oncotarget · doi:10.18632/oncotarget.13704 · Cited by 38
Self-citationLin, Y., Zheng, F., Jiang, T., Wan, Z., Pan, Y., Ma, Y., Shi, Y., Tan, Y., Dong, L., Zhang, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.017 · Cited by 35
β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
Kuo, T., Cheng, K., Shan, Y., Chen, L., & Hung, W.-C. (2018) · Theranostics · doi:10.7150/thno.28201 · Cited by 35
Recent Advances in Liquid Biopsy in Precision Oncology Research
Sato, Y., Matoba, R., & Kato, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00804 · Cited by 35
Felix, T. F., Lapa, R. M. L., de Carvalho, M., Bertoni, N., Tokár, T., de Oliveira, R. A., Rodrigues, M. A. M., Hasimoto, C. N., de Oliveira, W. K., Pelafsky, L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217421 · Cited by 36
Qi, X., Yu, C., Wang, Y., Lin, Y., & Shen, B. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0245-6 · Cited by 34
Clinically Actionable Strategies for Studying Neural Influences in Cancer
Demir, İ. E., Reyes, C. M., Alrawashdeh, W., Ceyhan, G. O., Deborde, S., Friess, H., Görgülü, K., Istvánffy, R., Jungwirth, D., Kuner, R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.023 · Cited by 34
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
Hayashi, H., Higashi, T., Miyata, T., Yamashita, Y., & Baba, H. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12436 · Cited by 36
PARI Overexpression Promotes Genomic Instability and Pancreatic Tumorigenesis
O’Connor, K. W., Dejsuphong, D., Park, E., Nicolae, C. M., Kimmelman, A. C., D’Andrea, A. D., & Moldovan, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3313 · Cited by 35
A microRNA meta-signature for pancreatic ductal adenocarcinoma
Frampton, A. E., Giovannetti, E., Jamieson, N. B., Krell, J., Gall, T., Stebbing, J., Jiao, L. R., & Castellano, L. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.893192 · Cited by 34
Bhaw‐Luximon, A., & Jhurry, D. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2178-4 · Cited by 34
State of the art biological therapies in pancreatic cancer
Marco, M. D. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i1.55 · Cited by 34
Quirin, K. A., Kwon, J. J., Alioufi, A., Factora, T. D., Temm, C. J., Jacobsen, M. H., Sandusky, G. E., Shontz, K., Chicoine, L. G., Clark, K. R., et al. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.09.006 · Cited by 35
Confirmation of a metastasis-specific microRNA signature in primary colon cancer
van den Braak, R. R. J. C., Sieuwerts, A. M., Lalmahomed, Z. S., Smid, M., Wilting, S. M., Bril, S. I., Xiang, S., van der Vlugt‐Daane, M., de Weerd, V., van Galen, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22532-1 · Cited by 34
Patel, N. M., Jo, H., Eberhard, D. A., Yin, X., Hayward, M. C., Stein, M. K., Hayes, D. N., & Grilley‐Olson, J. E. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000684 · Cited by 35
Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer
Chung, S., Vail, P. J., Witkiewicz, A. K., & Knudsen, E. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1620 · Cited by 34
Siljamäki, E., Rappu, P., Riihilä, P., Nissinen, L. M., Kähäri, V., & Heino, J. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.09.001 · Cited by 35
Rabenau, K. E., & Hofstatter, E. W. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.06.006 · Cited by 34
Masuda, S., Koizumi, K., Shionoya, K., Jinushi, R., Makazu, M., Nishino, T., Kimura, K. A., Sumida, C., Kubota, J., Ichita, C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i12.1863 · Cited by 33
Current Advances in Nanocarriers for Cancer Therapy
Zeinali, R., Zaeifi, D., Zolfaghari-Moghaddam, S. Y., Paul, M. K., & Biazar, E. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s548088 · Cited by 45
Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling
Fullerton, P. T., Creighton, C. J., & Matzuk, M. M. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1102 · Cited by 33
Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth
Vincent, A., Hong, S., Hu, C., Omura, N., Young, A., Kim, H., Yu, J., Knight, S., Ayars, M., Griffith, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1842 · Cited by 33
Self-citation
Metadata
- Authors
- Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., Wu, J., Chang, D. K., Cowley, M. J., Gardiner, B. B., Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., Gongora, M., Pajic, M., Scarlett, C. J., Gill, A. J., Pinho, A. V., Rooman, I., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Lynn Fink, J., Christ, A., Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Scott Mead, R., Humphris, J. L., Kaplan, W., Jones, M. D., Colvin, E. K., Nagrial, A. M., Humphrey, E. S., Chou, A., Chin, V. T., Chantrill, L. A., Mawson, A., Samra, J. S., Kench, J. G., Lovell, J. A., Daly, R. J., Merrett, N. D., Toon, C., Epari, K., Nguyen, N. Q., Barbour, A., Zeps, N., Kakkar, N., Zhao, F., Qing Wu, Y., Wang, M., Muzny, D. M., Fisher, W. E., Charles Brunicardi, F., Hodges, S. E., Reid, J. G., Drummond, J., Chang, K., Han, Y., Lewis, L. R., Dinh, H., Buhay, C. J., Beck, T., Timms, L., Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, R. E., Yung, C. K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P. A., Petersen, G. M., Gallinger, S., Hruban, R. H., Maitra, A., Iacobuzio-Donahue, C. A., Schulick, R. D., Wolfgang, C. L., Morgan, R. A., Lawlor, R. T., Capelli, P., Corbo, V., Scardoni, M., Tortora, G., Tempero, M. A., Mann, K. M., Jenkins, N. A., Perez-Mancera, P. A., Adams, D. J., Largaespada, D. A., Wessels, L. F. A., Rust, A. G., Stein, L. D., Tuveson, D. A., Copeland, N. G., Musgrove, E. A., Scarpa, A., Eshleman, J. R., Hudson, T. J., Sutherland, R. L., Wheeler, D. A., Pearson, J. V., McPherson, J. D., Gibbs, R. A., & Grimmond, S. M.
- Affiliations
- Garvan Institute of Medical Research (AU)
- The University of Queensland (AU)
- Ontario Institute for Cancer Research (CA)
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- St John of God Subiaco Hospital (AU)
- Baylor College of Medicine (US)
- University of California, Los Angeles (US)
- University Health Network (CA)
- Johns Hopkins University (US)
- University of Verona (IT)
- Houston Methodist (US)
- University of Minnesota (US)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Grimmond, Sean M.
- ORCID
- Biankin, Andrew V.
- Waddell, Nicola
- Kassahn, Karin S.
- Gingras, Marie-Claude
- Muthuswamy, Lakshmi B.
- Johns, Amber L.
- Wilson, Peter J.
- Patch, Ann-Marie
- Wu, Jianmin
- Chang, David K.
- Cowley, Mark J.
- Gardiner, Brooke B.
- Song, Sarah
- Harliwong, Ivon
- Nourbakhsh, Ehsan
- Manning, Suzanne
- Wani, Shivangi
- Pajic, Marina
- Scarlett, Christopher J.
- Gill, Anthony J.
- Pinho, Andreia V.
- Rooman, Ilse
- Anderson, Matthew
- Holmes, Oliver
- Leonard, Conrad
- Wood, Scott
- Christ, Angelika
- Cloonan, Nicole
- Newell, Felicity
- Pinese, Mark
- Kaplan, Warren
- Jones, Marc D.
- Colvin, Emily K.
- Nagrial, Adnan M.
- Chou, Angela
- Chin, Venessa T.
- Chantrill, Lorraine A.
- Mawson, Amanda
- Samra, Jaswinder S.
- Kench, James G.
- Daly, Roger J.
- Merrett, Neil D.
- Toon, Christopher
- Nguyen, Nam Q.
- Barbour, Andrew
- Zeps, Nikolajs
- Zhao, Fengmei
- Muzny, Donna M.
- Drummond, Jennifer
- Chang, Kyle
- Han, Yi
- Dinh, Huyen
- Beck, Timothy
- Begley, Kimberly
- Brown, Andrew
- Denroche, Robert E.
- Yung, Christina K.
- Serra, Stefano
- Mukhopadhyay, Debabrata
- Tsao, Ming-Sound
- Petersen, Gloria M.
- Hruban, Ralph H.
- Maitra, Anirban
- Schulick, Richard D.
- Wolfgang, Christopher L.
- Lawlor, Rita T.
- Corbo, Vincenzo
- Tortora, Giampaolo
- Tempero, Margaret A.
- Mann, Karen M.
- Jenkins, Nancy A.
- Adams, David J.
- Wessels, Lodewyk F. A.
- Rust, Alistair G.
- Stein, Lincoln D.
- Tuveson, David A.
- Scarpa, Aldo
- Eshleman, James R.
- Hudson, Thomas J.
- Wheeler, David A.
- Pearson, John V.
- McPherson, John D.
- Gibbs, Richard A.
- Grimmond, Sean M.
- Venue
- Nature
- Published
- 2012-10-24
- Volume
- 491
- Issue
- 7424
- Pages
- 399-405
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3530898
- OpenAlex
- W2161884651
- Cited by
- 2,058
- References
- 41
- Citations by year
- 2026: 62 · 2025: 98 · 2024: 90 · 2023: 128 · 2022: 173 · 2021: 190 · 2020: 168 · 2019: 163 · 2018: 159 · 2017: 187 · 2016: 191 · 2015: 176 · 2014: 157 · 2013: 113 · 2012: 1
- FWCI
- 70.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- American Association for Cancer Research
- Cancer Prevention and Research Institute of Texas (RP101353-P7, RP101353)
- Johns Hopkins University (P50CA062924)
- Royal College of Pathologists of Australasia
- Wellcome Trust
- Australian Government
- Cancer Research UK (13031)
- Australian Cancer Research Foundation
- Cancer Institute NSW
- Gastroenterological Society of Australia
- Royal Australasian College of Physicians
- Agency for Science, Technology and Research
- Petre Foundation
- Queensland Government
- R.T. Hall Trust
- Associazione Italiana per la Ricerca sul Cancro (12182, 5 x mille)
- Università degli Studi di Verona
- Ministero dello Sviluppo Economico
- National Institutes of Health (CA102701)
- Medical Research Council
- National Health and Medical Research Council (535914, 631701, 535903, 427601)
- Cancer Council NSW (SRP06-01)
- National Human Genome Research Institute (HG003273, U54HG003273)
- National Cancer Institute (CA102701, R01CA-97075, P01CA134292, P50CA101955, P50CA102701, R01CA113636, R01CA097075, P50CA062924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic ductal adenocarcinoma, axon guidance genes, somatic mutations, copy number variation, chromatin modification, DNA repair, ATM, carcinogenesis, pathway analysis, patient survival, Sleeping Beauty transposon mutagenesis, early-stage pancreatic cancer
- MeSH terms
- Animals, Axons, Humans, Mutation, Pancreatic Neoplasms, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Gene Dosage, Carcinoma, Pancreatic Ductal, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
